Related Experiment Video
Updated: Aug 29, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
[Neonatal chronic lung disease]
1Universidade de São Paulo (USP), São Paulo, SP, Brazil.
Insights
Neonatal chronic lung disease (CLD) is increasingly common in preterm infants. Management requires individualized treatment and crucial outpatient follow-up, addressing nutritional and social needs for better outcomes.
Area of Science:
- Neonatology
- Pediatric Pulmonology
Background:
- Chronic lung disease (CLD) in neonates is a growing concern due to improved survival rates of preterm infants.
- Understanding the pathophysiology of neonatal CLD is critical, with prematurity and respiratory support being key factors.
Purpose of the Study:
- To review the pathophysiology and outpatient follow-up of neonatal chronic lung disease.
- To highlight the complexities in diagnosis and management of this condition.
Main Methods:
- A comprehensive Medline search was conducted for relevant articles on neonatal chronic lung disease since its initial description in 1967.
- Review of existing literature to synthesize information on pathophysiology, treatment, and follow-up.
Main Results:
- Neonatal CLD incidence is rising, driven by increased survival of premature infants.
- Pathophysiology involves prematurity and respiratory assistance; treatment is complex and individualized, with controversial drug indications.
- Essential outpatient follow-up must encompass nutritional and social aspects for optimal prognosis.
Conclusions:
- Neonatal CLD is often under-recognized by pediatricians, especially concerning post-discharge care.
- Severe cases necessitate specialized centers with advanced resources.
- Prognosis varies widely, influenced by prematurity complications and timely intervention.
Abstract:
OBJECTIVE: The author presents a review about neonatal chronic lung disease, with particular emphasis on pathophysiology and outpatient follow up. METHODS: The most relevant articles concerning the disorder were selected through Medline search, from the initial description of the disease, in 1967.RESULTS: Neonatal chronic lung disease is a condition with growing incidence due to progressive increase in survival of preterm infants. Neonatal chronic lung disease pathophysiology involves several factors, but prematurity and respiratory assistance to the newborn seem to play a major role in the pathogenic process. The treatment of neonatal chronic lung disease is complex and must be individualized. Diuretics, corticosteroids and bronchodilators are the most frequently used drugs, but their indication and timing for use remain controversial. Patient follow-up after hospital discharge is essential for a good prognosis, and must include nutritional and social aspects. CONCLUSIONS: Neonatal chronic lung disease is still a condition scarcely known among pediatricians, particularly regarding treatment after hospital discharge. Severe cases should be treated in specialized centers with advanced laboratory and management resources. The prognosis is remarkably variable and also related to the presence of other prematurity sequelae and prompt intervention on the complications.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
